## 12. Other current assets

| Content assets         | September 30, 2024 | December 31, 2023 |
|------------------------|--------------------|-------------------|
| Prepaid expenses and other | 48               | 95                |
| Derivative assets         | 85               | 64                |
| **Total**                 | **147**          | **168**           |

Content asset amortization of €51 million and €53 million is included in cost of revenue in the interim condensed consolidated statement of operations for the three months ended September 30, 2024 and 2023, respectively. Content asset amortization of €154 and €156 million is included in cost of revenue in the interim condensed consolidated statement of operations for the nine months ended September 30, 2024 and 2023, respectively.

## 13. Equity and other reserves

As of September 30, 2024 and December 31, 2023, the Company had 205,375,133 and 201,343,630 ordinary shares issued and fully paid, respectively, with 3,296,488 and 4,200,241 ordinary shares held as treasury shares, respectively.

On August 20, 2021, the Company announced that the board of directors had approved a program to repurchase up to $1.0 billion of the Company's ordinary shares. Repurchase of up to 10,000,000 of the Company's ordinary shares were authorized at the Company's general meeting of shareholders on April 21, 2021. The repurchase program will expire on April 21, 2026. Since the commencement of this repurchase program and through September 30, 2024, 469,274 ordinary shares were repurchased for €190 million under this program.

For the three and nine months ended September 30, 2024, the Company issued and repurchased 1,000,000 and 3,900,000 of its own ordinary shares, respectively, from its Netherlands subsidiary at par value. For the three and nine months ended September 30, 2024, the Company reissued 1,151,583 and 4,803,753 treasury shares, respectively, upon the exercise of stock options and vesting of restricted stock units.

For the three and nine months ended September 30, 2023, the Company issued and repurchased 900,000 and 1,600,000 of its own ordinary shares, respectively, from its Netherlands subsidiary at par value. For the three and nine months ended September 30, 2023, the Company reissued 463,000 and 1,810,969 treasury shares, respectively, upon the exercise of stock options, vesting of restricted stock units and contingently issuable shares.

On July 25, 2024, the Company issued 118,891 ordinary shares and 1,188,910 beneficiary certificates upon the net settlement of 800,000 outstanding warrants.

As of September 30, 2024 and December 31, 2023, the Group's founders held 338,530,600 and 343,841,690 beneficiary certificates, respectively.